Duke Cancer Institute is a clinical research site located in Durham, North Carolina, United States 27705.
Crixeo Clinical Trials Trust Score: 33/100 (FAILING). This profile has not yet been claimed by the site owner.
Duke Cancer Institute has participated in 178 clinical trials with 74 currently active.
Therapeutic areas: Platinum-resistant Ovarian Cancer, Sarcoma, Myxoid/Round Cell Liposarcoma.
Sponsors: Genmab, Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Children's Oncology Group.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Durham
Trust Score: 33/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Duke Cancer Institute has a Crixeo Trust Score of 33/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Duke Cancer Institute has 178 clinical trials on record, with 74 currently active. Their work covers Platinum-resistant Ovarian Cancer, Sarcoma, Myxoid/Round Cell Liposarcoma.
Duke Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.